Figure 1.
Difference in SVR12 rate between black and non-black subjects for those with HCV GT1 alone and those with both HCV GT1 and HIV for 12-week regimens. CI: confidence interval; GT1: genotype 1; HCV: hepatitis C virus; SVR12: sustained virological response assessed 12 weeks following cessation of treatment; TE: treatment experienced; TN: treatment naive